SCHEMBL21378046

SCHEMBL21378046

Cc1ccc2c(c1)c1ccccc1n2-c1cc(-c2cccc(-n3c4ccccc4c4ccncc43)c2)cc(-n2c3ccccc3c3cc(C)ccc32)c1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.39
ELANE P08246 4/20 0.36
PIP4K2A P48426 1/20 0.34
ACHE P22303 2/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP11B1 P15538 1/20 0.32
MAOA P21397 1/20 0.32
PDE9A O76083 1/20 0.31
PDE1C Q14123 1/20 0.31
KDM4E B2RXH2 1/20 0.31
S1PR4 O95977 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
S1PR1 P21453 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396894 0.94 CYP11B2 (0.39) CYP11B2ELANEPIP4K2AACHEGRIN1
SCHEMBL21397076 0.90 CYP11B2 (0.38) CYP11B2PIP4K2ACYP11B1MAOAKDM4E
SCHEMBL21396880 0.90 CYP11B2 (0.38) CYP11B2PIP4K2ACYP11B1MAOAKDM4E
SCHEMBL21377909 0.90 ELANE (0.39) CYP11B2ELANEPIP4K2AACHEGRIN1
SCHEMBL21377952 0.89 CYP11B2 (0.38) CYP11B2CYP11B1MAOA
SCHEMBL21378021 0.89 CYP11B2 (0.38) CYP11B2CYP11B1MAOA
SCHEMBL21396832 0.88 CYP11B2 (0.34) CYP11B2PIP4K2AALDH1A1CYP11B1MAOA
SCHEMBL21378007 0.87 CYP11B2 (0.38) CYP11B2ELANEACHEGRIN1GRIN2A
SCHEMBL23912060 0.86 CYP11B2 (0.51) CYP11B2ALDH1A1CYP11B1MAOAKDM4E
SCHEMBL21378060 0.85 ALDH1A1 (0.34) CYP11B2ELANEALDH1A1KDM4ES1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11608333-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-03-21 US disclosed
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885ELANE 1300/4885PIP4K2A 3782/4885
US-11608333-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885ELANE 1300/4885PIP4K2A 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.